BACKGROUND OSA is associated with an increased risk of cardiovascular morbidity. A
driver of this is metabolic dysfunction and in particular type 2 diabetes mellitus (T2DM). Prior …

Over 20 years of evidence indicates a strong association between obstructive sleep apnea
(OSA) and cardiovascular disease. Although inflammatory processes have been heavily …

Carbonic anhydrase inhibition reduces apnoeic events in sleep disordered breathing.
Zonisamide inhibits carbonic anhydrase, and induces weight loss in obese patients. This …

Background. Published studies showed conflicting results of the associations between
adiponectin and leptin levels and obstructive sleep apnoea (OSA). In obese patients …

Objectives The aim of the study was to (1) evaluate whether position affects drug-induced
sleep endoscopy (DISE) findings in positional and nonpositional patients and (2) determine …

Objective The pathophysiological basis of obstructive sleep apnea (OSA) is not completely
understood and likely varies among patients. In this regard, some patients with OSA do not …

Obstructive sleep apnea syndrome (OSAS) is a common disorder that can lead to significant
cardiovascular complications. Several studies have reported increased platelet activation …

OBJECTIVE: Obstructive sleep apnea syndrome is characterized by repetitive obstruction of
the upper airways, and it is a risk factor for cardiovascular diseases. There have been …

Background and aim Short sleep duration and poor quality sleep are associated with
coronary heart disease (CHD) mortality; however, the underlying pathophysiologic process …

В статье анализируются причинно-следственные связи синдрома обструктивного
апноэ сна (СОАС) и сердечно-сосудистых заболеваний (ССЗ). При СОАС в ответ на …